Cathay Biotech Financials
| 688065 Stock | 45.37 0.17 0.38% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 371.7 M | 273.3 M |
|
|
Cathay | Select Account or Indicator |
Understanding current and past Cathay Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cathay Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Cathay Biotech's assets may result in an increase in income on the income statement.
Please note, the presentation of Cathay Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cathay Biotech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cathay Biotech's management manipulating its earnings.
Cathay Biotech Stock Summary
Cathay Biotech competes with Shanghai Broadband, Qingdao Choho, Qinghaihuading Industrial, Hunan TV, and Heilongjiang Transport. Cathay Biotech is entity of China. It is traded as Stock on SHG exchange.Specialization | Basic Materials, Materials |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100004447 |
| Business Address | Lvzhou Ring Road, |
| Sector | Chemicals |
| Industry | Materials |
| Benchmark | Dow Jones Industrial |
| Website | www.cathaybiotech.com |
| Phone | 86 21 5080 1916 |
You should never invest in Cathay Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Cathay Stock, because this is throwing your money away. Analyzing the key information contained in Cathay Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Cathay Biotech Key Financial Ratios
Cathay Biotech's financial ratios allow both analysts and investors to convert raw data from Cathay Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of Cathay Biotech over time and compare it to other companies across industries.| Revenue | 2.11 B | ||||
| Gross Profit | 2.44 B | ||||
| EBITDA | 608.83 M | ||||
| Net Income | 366.52 M | ||||
| Total Asset | 18.83 B |
Cathay Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cathay Biotech's current stock value. Our valuation model uses many indicators to compare Cathay Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cathay Biotech competition to find correlations between indicators driving Cathay Biotech's intrinsic value. More Info.Cathay Biotech is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Cathay Biotech is roughly 2.45 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cathay Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cathay Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Cathay Biotech Systematic Risk
Cathay Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cathay Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-two with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on Cathay Biotech correlated with the market. If Beta is less than 0 Cathay Biotech generally moves in the opposite direction as compared to the market. If Cathay Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cathay Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cathay Biotech is generally in the same direction as the market. If Beta > 1 Cathay Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Cathay Biotech Total Assets Over Time
Cathay Biotech December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cathay Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cathay Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cathay Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Cathay Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cathay Biotech's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.61 | |||
| Information Ratio | 0.0876 | |||
| Maximum Drawdown | 23.44 | |||
| Value At Risk | (4.41) | |||
| Potential Upside | 6.97 |
Complementary Tools for Cathay Stock analysis
When running Cathay Biotech's price analysis, check to measure Cathay Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cathay Biotech is operating at the current time. Most of Cathay Biotech's value examination focuses on studying past and present price action to predict the probability of Cathay Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cathay Biotech's price. Additionally, you may evaluate how the addition of Cathay Biotech to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |